|SB0670 Enrolled||LRB097 04433 RPM 44472 b|
AN ACT concerning regulation.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
The Pharmacy Practice Act is amended by changing
Section 26 as follows:
(225 ILCS 85/26)
(Section scheduled to be repealed on January 1, 2018)
Anti-epileptic drug product selection prohibited.
(a) The General Assembly finds that this Section is
necessary for the immediate preservation of the public peace,
health, and safety.
(b) In this Section:
means (i) any drug prescribed for the
treatment of epilepsy or (ii) a drug used to treat or prevent
"Epilepsy" means a neurological condition characterized by
"Seizure" means a brief disturbance in the electrical
activity of the brain.
(c) When the prescribing physician has indicated on the
original prescription "may not substitute", a pharmacist may
not interchange an anti-epileptic drug or formulation of an
anti-epileptic drug for the treatment of epilepsy without
|SB0670 Enrolled||- 2 -||LRB097 04433 RPM 44472 b|
notification and the documented consent of the prescribing
physician and the patient or the patient's parent, legal
guardian, or spouse.
This Section does not apply to medication
orders issued for anti-epileptic drugs for any in-patient care
in a licensed hospital.
(d) If a pharmacist substitutes any generic prescription in
place of a brand-name anti-epileptic drug, then the pharmacist
shall provide written notice to the patient no later than the
time the prescription is dispensed.
(Source: P.A. 94-936, eff. 6-26-06; 95-689, eff. 10-29-07.)